BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1791440)

  • 1. Pseudomycins, a family of novel peptides from Pseudomonas syringae possessing broad-spectrum antifungal activity.
    Harrison L; Teplow DB; Rinaldi M; Strobel G
    J Gen Microbiol; 1991 Dec; 137(12):2857-65. PubMed ID: 1791440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bioactive lipodepsipeptides from Pseudomonas syringae: the pseudomycins.
    Ballio A; Bossa F; Di Giorgio D; Ferranti P; Paci M; Pucci P; Scaloni A; Segre A; Strobel GA
    FEBS Lett; 1994 Nov; 355(1):96-100. PubMed ID: 7957970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecomycins, unique antimycotics from Pseudomonas viridiflava.
    Miller CM; Miller RV; Garton-Kenny D; Redgrave B; Sears J; Condron MM; Teplow DB; Strobel GA
    J Appl Microbiol; 1998 Jun; 84(6):937-44. PubMed ID: 9717277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of chlorine-substituent for the antifungal activity of syringomycin and syringotoxin, metabolites of the phytopathogenic bacterium Pseudomonas syringae pv. syringae.
    Grgurina I; Barca A; Cervigni S; Gallo M; Scaloni A; Pucci P
    Experientia; 1994 Feb; 50(2):130-3. PubMed ID: 8125171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive lipopeptides of ice-nucleating snow bacterium Pseudomonas syringae strain 31R1.
    Fiore A; Mannina L; Sobolev AP; Salzano AM; Scaloni A; Grgurina I; Fullone MR; Gallo M; Swasey C; Fogliano V; Takemoto JY
    FEMS Microbiol Lett; 2008 Sep; 286(2):158-65. PubMed ID: 18789127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and Identification of Two Antifungal Cyclic Peptides Produced by Bacillus amyloliquefaciens L-H15.
    Han Y; Zhang B; Shen Q; You C; Yu Y; Li P; Shang Q
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2202-12. PubMed ID: 26123083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new syringopeptin produced by bean strains of Pseudomonas syringae pv. syringae.
    Grgurina I; Mariotti F; Fogliano V; Gallo M; Scaloni A; Iacobellis NS; Lo Cantore P; Mannina L; van Axel Castelli V; Greco ML; Graniti A
    Biochim Biophys Acta; 2002 May; 1597(1):81-9. PubMed ID: 12009406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and structural characterization of bacillomycin F produced by a bacterial honey isolate active against Byssochlamys fulva H25.
    Lee H; Churey JJ; Worobo RW
    J Appl Microbiol; 2008 Sep; 105(3):663-73. PubMed ID: 18397260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal and fungicidal activities and erythrocyte toxicities of cyclic lipodepsinonapeptides produced by Pseudomonas syringae pv. syringae.
    Sorensen KN; Kim KH; Takemoto JY
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2710-3. PubMed ID: 9124827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of a novel small antifungal peptide from Bacillus megaterium D4 Isolated from the dung of wild plateau yak in China.
    Chen L; Chen W
    Protein Pept Lett; 2010 Apr; 17(4):542-6. PubMed ID: 19594429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of lipodepsipeptide toxins from Pseudomonas syringae pv. syringae with biological and model membranes: a comparison of syringotoxin, syringomycin, and two syringopeptins.
    Dalla Serra M; Fagiuoli G; Nordera P; Bernhart I; Della Volpe C; Di Giorgio D; Ballio A; Menestrina G
    Mol Plant Microbe Interact; 1999 May; 12(5):391-400. PubMed ID: 10226372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and antifungal activity of pseudomycin side-chain analogues. Part 1.
    Jamison J; Levy S; Sun X; Zeckner D; Current W; Zweifel M; Rodriguez M; Turner W; Chen SH
    Bioorg Med Chem Lett; 2000 Sep; 10(18):2101-5. PubMed ID: 10999480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and structural analysis of bamylocin A, novel lipopeptide from Bacillus amyloliquefaciens LP03 having antagonistic and crude oil-emulsifying activity.
    Lee SC; Kim SH; Park IH; Chung SY; Choi YL
    Arch Microbiol; 2007 Oct; 188(4):307-12. PubMed ID: 17530228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast genes involved in growth inhibition by Pseudomonas syringae pv. syringae syringomycin family lipodepsipeptides.
    Takemoto JY; Yu Y; Stock SD; Miyakawa T
    FEMS Microbiol Lett; 1993 Dec; 114(3):339-42. PubMed ID: 8288110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopeptide phytotoxins produced by Pseudomonas syringae pv. syringae: comparison of the biosurfactant and ion channel-forming activities of syringopeptin and syringomycin.
    Hutchison ML; Gross DC
    Mol Plant Microbe Interact; 1997 Apr; 10(3):347-54. PubMed ID: 9100379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional assignment of YvgO, a novel set of purified and chemically characterized proteinaceous antifungal variants produced by Bacillus thuringiensis SF361.
    Manns DC; Churey JJ; Worobo RW
    Appl Environ Microbiol; 2012 Apr; 78(8):2543-52. PubMed ID: 22307285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of novel 1, 2, 4-triazole derivatives as antifungal agent.
    Chai X; Yu S; Jiang Y; Zou Y; Wu Q; Zhang D; Jiang Y; Cao Y; Sun Q
    Arch Pharm Res; 2012 Nov; 35(11):1895-901. PubMed ID: 23212630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringopeptins, new phytotoxic lipodepsipeptides of Pseudomonas syringae pv. syringae.
    Ballio A; Barra D; Bossa F; Collina A; Grgurina I; Marino G; Moneti G; Paci M; Pucci P; Segre A
    FEBS Lett; 1991 Oct; 291(1):109-12. PubMed ID: 1936237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacisubin, an antifungal protein with ribonuclease and hemagglutinating activities from Bacillus subtilis strain B-916.
    Liu Y; Chen Z; Ng TB; Zhang J; Zhou M; Song F; Lu F; Liu Y
    Peptides; 2007 Mar; 28(3):553-9. PubMed ID: 17129637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive approach for the detection of antifungal compounds using a susceptible strain of Candida albicans and confirmation of in vivo activity with the Galleria mellonella model.
    Favre-Godal Q; Dorsaz S; Queiroz EF; Conan C; Marcourt L; Wardojo BP; Voinesco F; Buchwalder A; Gindro K; Sanglard D; Wolfender JL
    Phytochemistry; 2014 Sep; 105():68-78. PubMed ID: 24984572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.